Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase EARLY_PHASE1 1Phase 4 1Phase 3 1Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Classical hematology 1

Conditions

Venous Thromboembolism 3Neoplasms 2Venous Thrombosis 1Upper Extremity Deep Vein Thrombosis 1Thrombosis 1Multiple Myeloma 1Head and Neck Neoplasms 1Fibrosis 1Catheter-Related Infections 1Carcinoma, Hepatocellular 1

Interventions

Enoxaparin 2apixaban 1Heparin, Low-Molecular-Weight 1Arginine Vasopressin 1Arginine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Thrombosis × apixaban × Clear all
NCT07189897 2025-10-08

Apixaban or Enoxaparin After Head and Neck Cancer Surgery

State University of New York - Upstate Medical University

Phase 4 Recruiting
76 enrolled
Classical hematologyHead & Neck

Head and Neck Neoplasms, Thrombosis, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡